Table 1.
Numbers of MNCs and fibroblasts in the study groups
Study group | Number of MNCs (mean ± SD) | Number of fibroblasts (mean ± SD) |
---|---|---|
Control (n=7) | 2.75±1.16 | 2.00±0.53 |
Sham (n=7) | 24.71±7.36a | 2.85±0.37a |
MMC (n=7) | 10.42±4.27a,b | 1.57±0.53b |
Infliximab (n=7) | 5.25±1.28a,b | 1.37±0.51b |
Notes:
Control group compared with sham group (P<0.01);
treatment groups compared with sham group (P<0.01).
Abbreviations: MMC, mitomycin-C; MNCs, mononuclear cells; SD, standard deviation.